TheJakartaPost

Please Update your browser

Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.

Jakarta Post

Herbal medicine, drinks can't cure COVID-19: Ministry

Herbal medicine or drinks, locally known as jamu, can only relieve the symptoms of comorbidities, not the COVID-19 itself.

Dyaning Pangestika (The Jakarta Post)
Jakarta
Thu, August 6, 2020 Published on Aug. 6, 2020 Published on 2020-08-06T14:07:15+07:00

Change text size

Gift Premium Articles
to Anyone

Share the best of The Jakarta Post with friends, family, or colleagues. As a subscriber, you can gift 3 to 5 articles each month that anyone can read—no subscription needed!
Herbal medicine, drinks can't cure COVID-19: Ministry The Health Ministry has reaffirmed that herbal medicine and 'jamu' (traditional herbal drink) cannot be used to cure COVID-19 symptoms. (shutterstock.com/Wisnu Haryo Yudhanto/File)

The Health Ministry has reaffirmed that herbal medicine and jamu (traditional herbal drink) cannot be used to cure COVID-19 symptoms.

Akhmad Saikhu, the head of the ministry’s herbal and traditional medicine research and development division, said herbal medicine or drinks only worked to relieve comorbidity symptoms in a patient, rather than curing the coronavirus disease.

A comorbidity is a medical condition that co-occurs with another, according to the Oxford English Dictionary.

Jamu can only be used to relieve symptoms of comorbid diseases,” said Akhmad in a statement on Wednesday.

Read also: What you need to know about Indonesia's vaccine development

He added several misconceptions had been passed among the public that jamu could be used to cure the coronavirus disease. However, COVID-19 could only be cured with an antiviral drug, Akhmad went on to say.

COVID-19 antiviral drugs and vaccines are still being tested. State-owned pharmaceutical company PT Bio Farma is working with Padjadjaran University in West Java to launch Phase III clinical trials in humans of a vaccine produced by Sinovac Biotech of China in the near future.

A study from London School of Hygiene and Tropical Medicine researchers found that around 1.7 billion people in the world are at risk of becoming severely infected with COVID-19 due to a comorbidity or underlying health problems, such as obesity and heart disease.

Your Opinion Matters

Share your experiences, suggestions, and any issues you've encountered on The Jakarta Post. We're here to listen.

Enter at least 30 characters
0 / 30

Thank You

Thank you for sharing your thoughts. We appreciate your feedback.

Share options

Quickly share this news with your network—keep everyone informed with just a single click!

Change text size options

Customize your reading experience by adjusting the text size to small, medium, or large—find what’s most comfortable for you.

Gift Premium Articles
to Anyone

Share the best of The Jakarta Post with friends, family, or colleagues. As a subscriber, you can gift 3 to 5 articles each month that anyone can read—no subscription needed!

Continue in the app

Get the best experience—faster access, exclusive features, and a seamless way to stay updated.